![]() ![]() |
13:45-14:00
Registration |
|||
![]() ![]() |
14:00-14:10
Opening |
|||
![]() ![]() |
14:10-14:30
Disease course of Prodrome focusing on conversion, remission & biological marker |
|||
![]() ![]() |
14:30-14:50
Suicidality and Suicide prevention in mood disorder patients |
|||
![]() ![]() |
14:50-15:10
Efficacy and safety of rapid dose administration of quetiapine in blpolar depression |
|||
![]() ![]() |
15:10-15:30
Patient paying the price? Case experience of switching the medicine with two different drug release profiles |
|||
![]() ![]() |
15:30-15:45
Q&A |
|||
![]() ![]() |
15:45-15:50
Break session |
|||
![]() ![]() |
15:50-16:10
Timely use of SGA in recurrent MDD |
|||
![]() ![]() |
16:10-16:30
Quetiapine and treatment of depression |
|||
![]() ![]() |
16:30-16:50
Quetiapine extended-release as the add-on therapy for more control in patients with major depressive disorder (MDD) |
|||
![]() ![]() |
16:50-17:10
Starting treatment on a newly diagnosed psychiatric patient: Physicians' considerations beyond the direct cost of treatment |
|||
![]() ![]() |
17:10-17:25
Q&A |
|||
![]() ![]() |
17:25-17:30
Closing by Moderator |
|||